Current clinical practice gaps in the treatment of intermediate‐ and high‐risk non‐muscle‐invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette‐Guérin (BCG): results of an international individual patient data survey (IPDS)期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Current clinical practice gaps in the treatment of intermediate‐ and high‐risk non‐muscle‐invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette‐Guérin (BCG): results of an international individual patient data survey (IPDS)

Authors:	J Alfred Witjes Joan Palou Mark Soloway Donald Lamm Ashish M Kamat Maurizio Brausi Raj Persad Roger Buckley Marc Colombel Andreas Böhle

Institution:	1. Department of Urology, Radboud University Nijmegen Medical Centre, , Nijmegen, The Netherlands;2. Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, , Barcelona, Spain;3. Department of Urology, University of Miami School of Medicine, , Miami, FL, USA;4. Department of Surgery, University of Arizona, BCG Oncology, , Phoenix, AZ, USA;5. Department of Urology, MD Anderson Cancer Centre, , Houston, TX, USA;6. Department of Urology, AUSL Modena, , Modena, Italy;7. Department of Urology/Surgery, Bristol Royal Infirmary and Bristol Urological Institute, , Bristol, UK;8. Department of Urology, North York General Hospital, , Toronto, ON, Canada;9. Department of Urology, Claude Bernard University, H?pital Edouard Herriot, , Lyon, France;10. Department of Urology, HELIOS Agnes Karll Hospital, , Bad Schwartau, Germany

Abstract:

Keywords:	bacillus Calmette‐Gué rin (BCG) guideline adherence non‐muscle‐invasive bladder cancer (NMIBC) practice gaps physician survey